Biolux Technology, a leader in orthodontic technology, has secured $4.5 million in seed funding to launch a new digital platform for its flagship product, OrthoPulse. The investment, led by redalpine and Revere Partners, will also support the company in advancing clinical research and scaling operations. In addition to the funding, Biolux has appointed Raphael Pascaud as Chairman of the Board to help guide the company through its next phase of growth.
The new digital platform for OrthoPulse will offer real-time monitoring and treatment optimization for both orthodontists and patients. This innovation aims to provide faster, more efficient treatment options for patients and empower orthodontists with the tools they need to deliver exceptional care.
Raphael Pascaud brings a wealth of leadership experience to Biolux, having served in various board and executive positions in the dental industry. His expertise will be crucial in steering the company towards continued innovation and success.
The patented light-accelerated technology of OrthoPulse utilizes near-infrared light therapy to accelerate tooth movement, resulting in more reliable and efficient treatment. This approach not only shortens the orthodontic process but also addresses issues related to patient compliance and treatment costs.
The partnership with redalpine and Revere Partners and the appointment of Raphael Pascaud mark a significant milestone for Biolux as they continue to revolutionize orthodontics and provide exceptional patient outcomes. The company is committed to advancing clinical research, developing innovative solutions, and expanding its presence in the U.S. market.
Source
Photo credit orthodonticproductsonline.com